Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein L51 pseudogene 2 (MRPL51P2) is a processed pseudogene found in the human genome. Unlike its parent gene, MRPL51, which encodes a component of the mitochondrial ribosome involved in mitochondrial protein synthesis, MRPL51P2 does not encode a functional protein[1][2]. Pseudogenes generally arise from duplication or retrotransposition events and often accumulate mutations that prevent them from being translated into functional proteins[2]. While some pseudogenes can have regulatory roles, such as RNA-based decoy activities or microRNA interactions, no such function has been described for MRPL51P2[4]. MRPL51P2 is not considered a therapeutic target nor is it known to play a role in disease. Note: If your intent was to reference the functional mitochondrial ribosomal protein, the correct gene is "Mitochondrial ribosomal protein L51" (MRPL51), not MRPL51P2[5]. MRPL51 encodes a protein that is part of the large subunit of the mitochondrial ribosome, but MRPL51P2 is explicitly a pseudogene and does not produce an active protein.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L51 pseudogene 2 (MRPL51P2).